ServicenavigationHauptnavigationTrailKarteikarten

Forschungsstelle
INNOSUISSE
Projektnummer
18117.1 PFLS-LS
Projekttitel
STR001 as a Novel Treatment for Hearing Loss
Projekttitel Englisch
STR001 as a Novel Treatment for Hearing Loss

Texte zu diesem Projekt
 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
Anzeigen

Erfasste Texte


KategorieText
Kurzbeschreibung
(Deutsch)
STR001 as a Novel Treatment for Hearing Loss
Kurzbeschreibung
(Englisch)
STR001 as a Novel Treatment for Hearing Loss
Abstract
(Deutsch)
STR001 is a drug that Strekin aims to develop for the treatment of hearing loss. Damage to sensory hair cells in the inner ear is a primary cause of sensorineural hearing loss. The proposed drug has been shown to activate a target that favorably affects pathways implicated in hearing health. In this project, we conduct translational preclinical research of STR001 to enable fast entry into clinical development and value creation.
Abstract
(Englisch)
STR001 is a drug that Strekin aims to develop for the treatment of hearing loss. Damage to sensory hair cells in the inner ear is a primary cause of sensorineural hearing loss. The proposed drug has been shown to activate a target that favorably affects pathways implicated in hearing health. In this project, we conduct translational preclinical research of STR001 to enable fast entry into clinical development and value creation.